<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药前途汇 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-30T16:37:26+08:00</updated>
  <subtitle>「前途汇」通过网络和线下聚会：分享和传报全球医药行业信息资讯、技术项目、并购资源、代理品种。建立医药行业国际化的沟通桥梁、交易平台、学习园地。是中国医药行业人脉拓展、商务交流的“好圈子”。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>国家药监局：又有207个药品注册证书被注销</title>
    <updated>2020-12-30T15:16:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/BOiiwVqeF0rnu7lzdTW8pw</id>
    <link href="https://mp.weixin.qq.com/s/BOiiwVqeF0rnu7lzdTW8pw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【新药技术转让】日本原研治疗骨质疏松的“米诺膦酸片”已完成中试</title>
    <updated>2020-12-30T15:16:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/LLEgq2lxicslcS-zY9ZHvw</id>
    <link href="https://mp.weixin.qq.com/s/LLEgq2lxicslcS-zY9ZHvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【盘点】2020年批准的9个国产1类新药（多款首创）</title>
    <updated>2020-12-29T12:59:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/FEkSCS_fTgcJ3EepPL_TiA</id>
    <link href="https://mp.weixin.qq.com/s/FEkSCS_fTgcJ3EepPL_TiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>二合一降糖药市场巨大！4个“二甲双胍复方制剂”MAH合作</title>
    <updated>2020-12-29T12:59:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/ZtHQ84qeTN_-dsBeQ1S8NA</id>
    <link href="https://mp.weixin.qq.com/s/ZtHQ84qeTN_-dsBeQ1S8NA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【新会员】海药股份--可承接多种剂型的药品委托生产服务</title>
    <updated>2020-12-29T12:59:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/17IRNWlDj-4KN80eP8mJHQ</id>
    <link href="https://mp.weixin.qq.com/s/17IRNWlDj-4KN80eP8mJHQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《焦点访谈》：医保目录如何进？为何出？</title>
    <updated>2020-12-29T12:59:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/tgUvu_o5XntOMydaJunE_Q</id>
    <link href="https://mp.weixin.qq.com/s/tgUvu_o5XntOMydaJunE_Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>降！降！降！2020版医保目录出炉（附名录）</title>
    <updated>2020-12-28T11:10:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/uB-TPK7EIdMUnK-wPATnfg</id>
    <link href="https://mp.weixin.qq.com/s/uB-TPK7EIdMUnK-wPATnfg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【药学CRO】天津汉康医药可合作新药项目推荐</title>
    <updated>2020-12-28T11:10:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/prpfAp1vt45TlAyHImVNgg</id>
    <link href="https://mp.weixin.qq.com/s/prpfAp1vt45TlAyHImVNgg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大品种推荐：碳酸钙D3片/咀嚼片/颗粒技术成熟，免BE，接受再开发</title>
    <updated>2020-12-28T11:10:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/KkqIaPxRKzBlfD3hEGbvGw</id>
    <link href="https://mp.weixin.qq.com/s/KkqIaPxRKzBlfD3hEGbvGw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【中药大政策】促进已上市中药质量竞争，支持同名同方药的研制</title>
    <updated>2020-12-26T19:29:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/FkP6lyQii7oa9PbPUvSYTQ</id>
    <link href="https://mp.weixin.qq.com/s/FkP6lyQii7oa9PbPUvSYTQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【议程及展商更新】前途汇药品生产文号和新药技术交易会杭州站邀请函</title>
    <updated>2020-12-25T17:12:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/sZ_vyDDNriwM-LgcBdqvPA</id>
    <link href="https://mp.weixin.qq.com/s/sZ_vyDDNriwM-LgcBdqvPA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>浅析：从机体/技术/政策/现状，看儿童药开发的艰辛！</title>
    <updated>2020-12-24T15:13:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/tZVgAcDGe8Pk0Tpz67eRYA</id>
    <link href="https://mp.weixin.qq.com/s/tZVgAcDGe8Pk0Tpz67eRYA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>南京恒道医药│有着较高“项目成功率”的专业药学研发一站式CRO</title>
    <updated>2020-12-24T15:13:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/asy7wjoeWYbgnIaHwS3B-A</id>
    <link href="https://mp.weixin.qq.com/s/asy7wjoeWYbgnIaHwS3B-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>糖尿病并发症重磅药物：“依帕司他片”MAH合作</title>
    <updated>2020-12-24T15:13:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/xbcTEPJb6qH-M8r1gR6unA</id>
    <link href="https://mp.weixin.qq.com/s/xbcTEPJb6qH-M8r1gR6unA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年值得研发的7款化药仿制药推荐（技术转让）</title>
    <updated>2020-12-23T13:58:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/XfFA2GMSNA_jHHra7FJJ1A</id>
    <link href="https://mp.weixin.qq.com/s/XfFA2GMSNA_jHHra7FJJ1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗肿瘤重磅品种“伊布替尼胶囊”技术转让，可立即落户放大及工艺验证</title>
    <updated>2020-12-23T13:58:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/4nVpqAigzwhRm4IbHbS65Q</id>
    <link href="https://mp.weixin.qq.com/s/4nVpqAigzwhRm4IbHbS65Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【盘点】已有89家企业获得“药品生产许可B证”布局MAH交易市场</title>
    <updated>2020-12-22T12:46:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/93FBktixBHWVhXleVhpAgg</id>
    <link href="https://mp.weixin.qq.com/s/93FBktixBHWVhXleVhpAgg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【新会员】山东盛之源--“新药/仿制药”研发和检测一体化服务平台</title>
    <updated>2020-12-22T12:46:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/rVuxmx0XJI5kXvZ3OSzKgg</id>
    <link href="https://mp.weixin.qq.com/s/rVuxmx0XJI5kXvZ3OSzKgg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>唯一双重作用机制抗过敏药：“富马酸卢帕他定片”技术转让</title>
    <updated>2020-12-22T12:46:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/vLi2qXlu8RCpQE98iwDxQg</id>
    <link href="https://mp.weixin.qq.com/s/vLi2qXlu8RCpQE98iwDxQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>乔迁之喜|祝贺重庆恒誉康暨恒真维实医药科技有限公司乔迁庆典圆满礼成</title>
    <updated>2020-12-22T12:46:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/9-Uy3PxEqV2kvi2BfjgSfQ</id>
    <link href="https://mp.weixin.qq.com/s/9-Uy3PxEqV2kvi2BfjgSfQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>